What Researchers Did
Researchers conducted a retrospective case review of 33 patients to describe the presentation and management of osteoradionecrosis (ORN) of the temporal bone following head and neck radiation.
What They Found
Among 33 patients, the most common primary tumor sites were the parotid gland (n=11) and nasopharynx (n=7), with ORN developing between 1 and 22 years (mean 7.9 years) after radiation. The mean radiation dose to the affected temporal bone was 53.1 Gy, and common symptoms included otorrhea (n=15), hearing loss (n=13), and otalgia (n=12). While conservative therapy managed symptoms, it often failed to eradicate exposed bone, with surgery reserved for recalcitrant cases.
What This Means for Canadian Patients
Canadian patients who have received head and neck radiation should be aware of the potential for osteoradionecrosis of the temporal bone, even years after treatment. Early recognition of symptoms like ear discharge, hearing loss, or ear pain is important for timely management, which may involve conservative or surgical approaches.
Canadian Relevance
This study has no direct Canadian connection as it was conducted at an academic medical center outside of Canada.
Study Limitations
As a retrospective case series, this study is limited by its lack of a control group and potential for selection bias.